Innerpink Feminine Spot
FDA Label NDC 73819-0015

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Gustar Co., Ltd. for the product Innerpink Feminine Spot (NDC 73819-0015). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient(s), inactive ingredients, purpose, warnings, keep out of reach of children, use(s), directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings

For external use only
1. In case of using cosmetics or after use, please consult a specialist if there is any abnormal symptom or side effect such as red spot, swelling or itching in direct sunlight.
2. Do not use on wounded areas.
3. Precautions for storage and handling
a) Keep out of reach of children.
b) Avoid direct sunlight.

Other Information

■ Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light.

Questions

■ www.innerpink.co.kr

* Please review the disclaimer below.